Novartis India
- All
- News
- Videos
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Novartis India Sheds Over 6% Even After Net Profit Rises 43% In March Quarter
Novartis India Share Price Today: On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, so far
-
Stocks To Watch: PowerGrid Corporation, Novartis India, Natco Pharma
PowerGrid Corporation reported a 6 per cent rise in consolidated net profit to Rs 3,526.23 crore in the quarter ended March 2021 from Rs 3,313.47 crore in the same quarter last fiscal
-
Gujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old Son
A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder.
-
ISB 2017 Placements: Average Salary Of Rs 22 Lakh, Over 400 Recruiters
Regular recruiters at ISB placement activities included Microsoft, Citibank, Amazon, Cognizant, and Hindustan Unilever, Novartis, Siemens, McKinsey, BCG, Parthenon and AT Kearney.
-
Sun Pharma To Acquire Oncology Product From Novartis For $175 Million
Odomzo was approved by the USFDA in July 2015. It is indicated for the treatment of adult patients with locally advanced basal cell carcinoma.
-
Novartis Q2 Net Profit At Rs 22 Crore
Pharma company Novartis India today reported a standalone net profit of Rs 22.21 crore for the quarter ended September 30, 2016.
-
Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test
Both Shanghvi's eye for value and his tenaciousness were exemplified in the 2010 takeover of Israel-based Taro Pharmaceutical Industries Ltd.
-
Sun Pharma Inks Distribution Alliance With Mitsubishi Tanabe
Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million.
-
Novartis India Q1 Net Profit At Rs 19 Crore
Drug firm Novartis India reported a standalone net profit of Rs 19.07 crore for the first quarter ended June 30, 2016.
-
Novartis Slumps On Q4 Result Disappointment
Shares of drug firm Novartis India on Friday slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016.
-
Novartis Posts Rs 22 Crore Profit In Q4
Drug firm Novartis India on Thursday reported a standalone net profit of Rs 21.53 crore for the quarter ended March 31, 2016.
-
Lupin To Market Novartis' Inhaler Under Loftair Brand Name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India.
-
Sun Pharma Rises as Company Buys 14 Brands From Novartis
Shares of Sun Pharma rose by nearly 3 per cent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
-
Sun Pharma Enters Japanese Market, Buys 14 Brands from Novartis
Drug major Sun Pharma has forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Novartis India Sheds Over 6% Even After Net Profit Rises 43% In March Quarter
Novartis India Share Price Today: On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, so far
-
Stocks To Watch: PowerGrid Corporation, Novartis India, Natco Pharma
PowerGrid Corporation reported a 6 per cent rise in consolidated net profit to Rs 3,526.23 crore in the quarter ended March 2021 from Rs 3,313.47 crore in the same quarter last fiscal
-
Gujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old Son
A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder.
-
ISB 2017 Placements: Average Salary Of Rs 22 Lakh, Over 400 Recruiters
Regular recruiters at ISB placement activities included Microsoft, Citibank, Amazon, Cognizant, and Hindustan Unilever, Novartis, Siemens, McKinsey, BCG, Parthenon and AT Kearney.
-
Sun Pharma To Acquire Oncology Product From Novartis For $175 Million
Odomzo was approved by the USFDA in July 2015. It is indicated for the treatment of adult patients with locally advanced basal cell carcinoma.
-
Novartis Q2 Net Profit At Rs 22 Crore
Pharma company Novartis India today reported a standalone net profit of Rs 22.21 crore for the quarter ended September 30, 2016.
-
Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test
Both Shanghvi's eye for value and his tenaciousness were exemplified in the 2010 takeover of Israel-based Taro Pharmaceutical Industries Ltd.
-
Sun Pharma Inks Distribution Alliance With Mitsubishi Tanabe
Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million.
-
Novartis India Q1 Net Profit At Rs 19 Crore
Drug firm Novartis India reported a standalone net profit of Rs 19.07 crore for the first quarter ended June 30, 2016.
-
Novartis Slumps On Q4 Result Disappointment
Shares of drug firm Novartis India on Friday slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016.
-
Novartis Posts Rs 22 Crore Profit In Q4
Drug firm Novartis India on Thursday reported a standalone net profit of Rs 21.53 crore for the quarter ended March 31, 2016.
-
Lupin To Market Novartis' Inhaler Under Loftair Brand Name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India.
-
Sun Pharma Rises as Company Buys 14 Brands From Novartis
Shares of Sun Pharma rose by nearly 3 per cent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
-
Sun Pharma Enters Japanese Market, Buys 14 Brands from Novartis
Drug major Sun Pharma has forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
